PerspectiveVaccine Design

Vaccine Design Reaches the Atomic Level

See allHide authors and affiliations

Science Translational Medicine  13 Jul 2011:
Vol. 3, Issue 91, pp. 91ps29
DOI: 10.1126/scitranslmed.3002807

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The genetic diversity of pathogens presents a challenge to the development of broadly effective vaccines. In this issue, Scarselli et al. combine atomic-level structural information with genomics and classical vaccinology to design a single immunogen that elicits protective immunity against more than 300 natural variants of the bacterial pathogen meningococcus B. This accomplishment provides a glimpse of the power of structure-based vaccine design to create immunogens capable of eliciting protective responses against genetically diverse pathogens.


  • Citation: P. D. Kwong, L. Shapiro, Vaccine Design Reaches the Atomic Level. Sci. Transl. Med. 3, 91ps29 (2011).

View Full Text

Stay Connected to Science Translational Medicine